查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年金奈米颗粒市场预测：按类型、应用、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1383466

到 2030 年金奈米颗粒市场预测：按类型、应用、最终用户和地区分類的全球分析

Gold Nanoparticles Market Forecasts to 2030 - Global Analysis By Type, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球金奈米颗粒市场规模为38.1亿美元，预计2030年将达到98.9亿美元，预测期内年复合成长率为14.6%。

金奈米颗粒是一种用途广泛、研究广泛的奈米材料，典型尺寸范围为 1 至 100 奈米。它们独特的光学特性，包括与尺寸和形状相关的明亮颜色，使其可用于成像、药物传输和医疗诊断。这些奈米颗粒因其生物相容性而受到高度重视，可实现标靶治疗和生物感测器。

根据美国测试与材料协会 (ASTM International 2006) 的说法，奈米颗粒是具有二维或更多维度且尺寸范围为 1 至 100 nm 的颗粒。

日益增长的环境问题

随着空气和水污染等环境问题的日益严重，金奈米颗粒越来越受欢迎。金奈米颗粒用于许多环境应用，例如空气污染监测和水净化。此外，金奈米粒子催化污染物降解的能力及其在环境毒素检测感测器中的应用与世界对环境保护和永续性的关注相一致。

生产成本高

原料成本、能源使用和合成技术的难度是影响金奈米颗粒製造成本的一些变数。由于特殊应用需要精确控制尺寸和形状，因此製造成本很高。此外，由于在大批量生产中保持品质和粒度分布一致性的技术挑战，实现规模经济可能很困难。对成本敏感的行业和应用的采用可能会受到此成本因素的限制。

医疗领域的发展

使用金奈米粒子在医学领域有很多可能性。其特殊的性质可以实现药物的靶向输送，从而实现精确的药物输送，同时减少副作用。它也是疾病早期诊断和检测的有用工具，特别是感染疾病和癌症的诊断。此外，随着医学研究的进步，金奈米粒子有可能透过提高治疗效果和诊断准确性来彻底改变医疗保健。

与不同奈米材料的竞争

金奈米颗粒面临的主要竞争威胁之一是开发具有可比或更好性能但成本更低的替代奈米材料。而且，量子点、奈米银、碳基奈米材料等材料都有可能改变消费者的需求，所以企业不断想出新的想法，宣传奈米金的特殊好处，我必须继续下去。

COVID-19 的影响：

金奈米颗粒市场受到了 COVID-19大流行的各种影响。一方面，由于疫苗输送和诊断等医疗和诊断应用对金奈米颗粒的需求不断增加，市场不断增长。即使在疫情过后，金奈米粒子的市场预计仍将扩大，特别是在环境和医疗保健产业。然而，要警惕供应链的弱点和经济的不可预测性。

预计药物传输领域在预测期内将是最大的

药物传输领域预计将占据最大的市场份额。金奈米颗粒的特殊性质使其在药物传输应用中非常受欢迎。透过设计这些奈米粒子，可以将治疗药物精确地递送到特定的细胞和组织。透过对金奈米粒子表面进行功能化，可以提高其生物相容性并延长血液循环。此外，它们的尺寸和形状可以调整，因此可以客製化以满足您的特定治疗需求。

生技公司领域预计在预测期内年复合成长率最高。

在金奈米粒子市场中，复合年复合成长率最高的领域是生技公司。金奈米粒子在药物传输、成像、诊断和治疗等生物技术应用中越来越普及。金奈米粒子由于其特殊的光学、热和电特性而非常适合用于生物医学应用。此外，具有特定配体和生物分子的金奈米颗粒的功能化可以进一步增强其在标靶药物递送和成像方面的潜力。

比最大的地区

北美，包括美国和加拿大，在金奈米粒子市场中占据最大份额。该地区因其在材料科学、医疗保健和奈米技术方面强大的研发实力而拥有强大的市场影响力。此外，由于北美研究机构、製药公司和生物技术公司的努力，对金奈米粒子的需求正在显着增长。

复合年复合成长率最高的地区：

预计欧洲地区金奈米粒子市场的年复合成长率最高。此外，金奈米粒子具有广泛的应用，包括成像、药物传输和诊断，而医疗保健和生物技术研究的这些发展是其显着增长的来源。凭藉对奈米技术研究的大力支持和对创新的奉献，欧洲有望引领市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球金奈米颗粒市场：依类型

  • 基于金奈米颗粒的药物传输系统
  • 聚乙二醇化金奈米颗粒
  • 金奈米壳
  • 金奈米粒子显影剂
  • 其他类型

第6章全球金奈米颗粒市场：依应用分类

  • 感应器
  • 光热疗法
  • 电子产品
  • 创伤治疗
  • 化妆品
  • 奈米流体
  • 食品工业
  • 纺织品
  • 净水
  • 药物输送
  • 其他用途

第7章全球金奈米颗粒市场：依最终用户分类

  • 製药公司
  • 医院和诊所
  • 研究机构
  • 生技公司
  • 牙医诊所
  • 动物医院
  • 其他最终用户

第8章全球金奈米颗粒市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • NanoComposix
  • Agilent Technologies Inc.
  • Expedeon Ltd.
  • BBI Solutions
  • NanoHybrids Inc
  • Meliorum Technologies Inc
  • Cline Scientific
  • Nanopartz Inc
  • Goldsol Inc
  • Abcam plc
  • Merck Group
  • Cytodiagnostics Inc
  • Nanosphere Inc
  • Metalor Technologies International
  • Solaris Nanosciences Corporation
  • Sigma-Aldrich
  • Tanaka Holdings Co., Ltd
  • Sona Nanotech Inc
  • Strem Chemicals Inc.
Product Code: SMRC24314

According to Stratistics MRC, the Global Gold Nanoparticles Market is accounted for $3.81 billion in 2023 and is expected to reach $9.89 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Gold nanoparticles are a versatile and widely studied nanomaterial, with typical sizes ranging from 1 to 100 nanometers. Their unique optical characteristics, such as their size- and shape-dependent vivid colors, make them useful for imaging, medication delivery, and medical diagnostics. Due to their biocompatibility, which enables targeted treatments and biosensors, these nanoparticles are highly valued.

According to American Society for Testing and Materials (ASTM international 2006), nanoparticles are those particles which have two or more than two dimensions and are in the size range of 1 - 100 nm.

Market Dynamics:

Driver:

Growing Concerns about the Environment

Gold nanoparticles are becoming more popular as environmental concerns-such as air and water pollution-get bigger. They are used in a number of environmental applications, including air pollution monitoring and water purification. Moreover, the ability of gold nanoparticles to catalyze the breakdown of pollutants and their application in environmental toxin detection sensors are in line with the global focus on environmental protection and sustainability.

Restraint:

High production expenses

The cost of raw materials, energy usage, and the difficulty of synthesis techniques are some of the variables that affect the cost of producing gold nanoparticles. Higher production costs result from the need for precise control over size and shape in specialized applications. Furthermore, it can be difficult to achieve economies of scale because it can be technically difficult to maintain consistency in quality and size distribution at higher volumes. Their adoption in cost-sensitive industries and applications may be restricted by this cost factor.

Opportunity:

Developments in medicine

There are a lot of opportunities in the field of medicine with gold nanoparticles. Their special qualities can be used to deliver drugs with precision and fewer side effects by allowing for targeted delivery. They are also useful instruments for early illness diagnosis and detection, particularly in the diagnosis of infectious diseases and cancer. Additionally, gold nanoparticles have the potential to completely transform healthcare as medical research progresses by increasing treatment efficacy and diagnostic precision.

Threat:

Rivalry with different nanomaterials

One major competitive threat to gold nanoparticles is the development of substitute nanomaterials with comparable or better properties but at a lower price. Moreover, materials like quantum dots, silver nanoparticles, and carbon-based nanomaterials can change consumer demand, which forces businesses to keep coming up with new ideas and showcasing the special benefits of gold nanoparticles.

COVID-19 Impact:

The market for gold nanoparticles has been affected by the COVID-19 pandemic in many ways. On the one hand, the market was growing due to the increase in demand for gold nanoparticles in medical and diagnostic applications, such as vaccine delivery and diagnostics. The market for gold nanoparticles is anticipated to expand after the pandemic passes, especially in the environmental and healthcare industries. However, caution should be exercised regarding supply chain weaknesses and economic unpredictability.

The Drug Delivery segment is expected to be the largest during the forecast period

The drug delivery segment is anticipated to hold the largest share in the market. The special qualities of gold nanoparticles have made them very popular in drug delivery applications. Therapeutic agents can be precisely delivered to particular cells or tissues by engineering these nanoparticles. It is possible to functionalize the surface of gold nanoparticles to improve their biocompatibility and lengthen their bloodstream circulation. Furthermore, they can be customized to meet specific therapeutic needs thanks to their adjustable size and shape.

The Biotechnology Companies segment is expected to have the highest CAGR during the forecast period

In the market for gold nanoparticles, the segment with the highest CAGR is biotechnology companies. Gold nanoparticles are becoming more and more popular in biotechnology applications such as drug delivery, imaging, diagnostics, and therapeutics. Gold nanoparticles are ideal for use in biomedical applications because of their special optical, thermal, and electrical characteristics. Moreover, the potential of gold nanoparticles in targeted drug delivery and imaging can be further enhanced by functionalizing them with particular ligands and biomolecules.

Region with largest share:

North America, which includes both the United States and Canada, holds the largest share of the market for gold nanoparticles. Due to the region's intense research and development efforts in material science, healthcare, and nanotechnology, it has a strong market presence. Moreover, the demand for gold nanoparticles has grown significantly, in large part due to the efforts of research institutions, pharmaceutical companies, and biotechnology firms in North America.

Region with highest CAGR:

In the market for gold nanoparticles, the European region is anticipated to have the highest CAGR. Additionally, gold nanoparticles find wide-ranging applications in imaging, drug delivery, and diagnostics; these developments in healthcare and biotechnology research are the source of this noteworthy growth. With its strong support for nanotechnology research and its dedication to innovation, Europe is well-positioned to lead the way in propelling market expansion.

Key players in the market

Some of the key players in Gold Nanoparticles market include: NanoComposix , Agilent Technologies Inc., Expedeon Ltd., BBI Solutions, NanoHybrids Inc, Meliorum Technologies Inc, Cline Scientific, Nanopartz Inc, Goldsol Inc, Abcam plc, Merck Group, Cytodiagnostics Inc, Nanosphere Inc, Metalor Technologies International, Solaris Nanosciences Corporation , Sigma-Aldrich , Tanaka Holdings Co., Ltd, Sona Nanotech Inc and Strem Chemicals Inc.

Key Developments:

In October2023, TANAKA, a core company of the TANAKA Precious Metals Group, has developed a high-entropy alloy powder composed entirely of precious metals with a fine particle size of 10um or less, high crystallinity and excellent composition uniformity. This is the world's first high-entropy alloy powder composed entirely of five precious metals: platinum, palladium, iridium, ruthenium, and rhodium. TANAKA has established a mass production process and will provide samples in October.

In March 2023, Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia, a leader in digital pathology to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

In May 2020, NanoComposix has established a partnership with Amplicon Biotech to expand access for customers across India to the suite of products and services offered by nanoComposix, a manufacturer of a variety of nanoparticle products for use in lateral flow assays, drug delivery, anti-microbials, optical displays, among other applications.

Types Covered:

  • Gold Nanoparticle-Based Drug Delivery Systems
  • Pegylated Gold Nanoparticles
  • Gold Nanoshells
  • Gold Nanoparticle-Based Contrast Agents
  • Other Types

Applications Covered:

  • Sensors
  • Photothermal Therapy
  • Electronics
  • Wound Healing
  • Cosmetics
  • Nanofluids
  • Food Industry
  • Textiles
  • Water Purification
  • Drug Delivery
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Hospitals and Clinics
  • Research Institutions
  • Biotechnology Companies
  • Dental Clinics
  • Veterinary Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gold Nanoparticles Market, By Type

  • 5.1 Introduction
  • 5.2 Gold Nanoparticle-Based Drug Delivery Systems
  • 5.3 Pegylated Gold Nanoparticles
  • 5.4 Gold Nanoshells
  • 5.5 Gold Nanoparticle-Based Contrast Agents
  • 5.6 Other Types

6 Global Gold Nanoparticles Market, By Application

  • 6.1 Introduction
  • 6.2 Sensors
  • 6.3 Photothermal Therapy
  • 6.4 Electronics
  • 6.5 Wound Healing
  • 6.6 Cosmetics
  • 6.7 Nanofluids
  • 6.8 Food Industry
  • 6.9 Textiles
  • 6.10 Water Purification
  • 6.11 Drug Delivery
  • 6.12 Other Applications

7 Global Gold Nanoparticles Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical Companies
  • 7.3 Hospitals and Clinics
  • 7.4 Research Institutions
  • 7.5 Biotechnology Companies
  • 7.6 Dental Clinics
  • 7.7 Veterinary Clinics
  • 7.8 Other End Users

8 Global Gold Nanoparticles Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 NanoComposix
  • 10.2 Agilent Technologies Inc.
  • 10.3 Expedeon Ltd.
  • 10.4 BBI Solutions
  • 10.5 NanoHybrids Inc
  • 10.6 Meliorum Technologies Inc
  • 10.7 Cline Scientific
  • 10.8 Nanopartz Inc
  • 10.9 Goldsol Inc
  • 10.10 Abcam plc
  • 10.11 Merck Group
  • 10.12 Cytodiagnostics Inc
  • 10.13 Nanosphere Inc
  • 10.14 Metalor Technologies International
  • 10.15 Solaris Nanosciences Corporation
  • 10.16 Sigma-Aldrich
  • 10.17 Tanaka Holdings Co., Ltd
  • 10.18 Sona Nanotech Inc
  • 10.19 Strem Chemicals Inc.

List of Tables

  • Table 1 Global Gold Nanoparticles Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gold Nanoparticles Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Gold Nanoparticles Market Outlook, By Gold Nanoparticle-Based Drug Delivery Systems (2021-2030) ($MN)
  • Table 4 Global Gold Nanoparticles Market Outlook, By Pegylated Gold Nanoparticles (2021-2030) ($MN)
  • Table 5 Global Gold Nanoparticles Market Outlook, By Gold Nanoshells (2021-2030) ($MN)
  • Table 6 Global Gold Nanoparticles Market Outlook, By Gold Nanoparticle-Based Contrast Agents (2021-2030) ($MN)
  • Table 7 Global Gold Nanoparticles Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Gold Nanoparticles Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global Gold Nanoparticles Market Outlook, By Sensors (2021-2030) ($MN)
  • Table 10 Global Gold Nanoparticles Market Outlook, By Photothermal Therapy (2021-2030) ($MN)
  • Table 11 Global Gold Nanoparticles Market Outlook, By Electronics (2021-2030) ($MN)
  • Table 12 Global Gold Nanoparticles Market Outlook, By Wound Healing (2021-2030) ($MN)
  • Table 13 Global Gold Nanoparticles Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 14 Global Gold Nanoparticles Market Outlook, By Nanofluids (2021-2030) ($MN)
  • Table 15 Global Gold Nanoparticles Market Outlook, By Food Industry (2021-2030) ($MN)
  • Table 16 Global Gold Nanoparticles Market Outlook, By Textiles (2021-2030) ($MN)
  • Table 17 Global Gold Nanoparticles Market Outlook, By Water Purification (2021-2030) ($MN)
  • Table 18 Global Gold Nanoparticles Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 19 Global Gold Nanoparticles Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 20 Global Gold Nanoparticles Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Gold Nanoparticles Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 22 Global Gold Nanoparticles Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 23 Global Gold Nanoparticles Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 24 Global Gold Nanoparticles Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 25 Global Gold Nanoparticles Market Outlook, By Dental Clinics (2021-2030) ($MN)
  • Table 26 Global Gold Nanoparticles Market Outlook, By Veterinary Clinics (2021-2030) ($MN)
  • Table 27 Global Gold Nanoparticles Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.